Stay updated on Inotuzumab Ozogamicin for B-ALL MRD+ Clinical Trial

Sign up to get notified when there's something new on the Inotuzumab Ozogamicin for B-ALL MRD+ Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Inotuzumab Ozogamicin for B-ALL MRD+ Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.2 to v3.8.0, while the study record content appears unchanged.
    Difference
    0.1%
    Check dated 2026-10-31T12:53:50.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A sitewide NIH notice announces transition updates and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    0.6%
    Check dated 2026-10-24T14:34:52.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-17T14:22:08.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The website footer now displays revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-10T14:27:44.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    A new revision entry, v3.7.0, is added to the record history and the prior revision, v3.6.6, is removed, signaling an update to the study record’s documentation. This reflects an updated version of the study record rather than changes to participant data or study results.
    Difference
    0.1%
    Check dated 2026-09-19T18:36:40.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    The record history was updated to add a new revision entry v3.6.6 and remove the previous revision v3.6.5, reflecting a change to the page's version history.
    Difference
    0.1%
    Check dated 2026-08-29T18:46:31.000Z thumbnail image

Stay in the know with updates to Inotuzumab Ozogamicin for B-ALL MRD+ Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Inotuzumab Ozogamicin for B-ALL MRD+ Clinical Trial page.